arginine-glycine-aspartate-o-methyltyrosine amide has been researched along with Thrombopenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorczynski, RJ; King, LW; Miyano, M; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Taite, BB; Tjoeng, FS; Williams, MH; Zupec, ME | 1 |
1 other study(ies) available for arginine-glycine-aspartate-o-methyltyrosine amide and Thrombopenia
| Article | Year |
|---|---|
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
Topics: Animals; Collagen; Dogs; Fibrinogen; Humans; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombocytopenia | 1991 |